Kociolek et al., 2016 - Google Patents
Clinical utility of laboratory detection of Clostridium difficile strain BI/NAP1/027Kociolek et al., 2016
View PDF- Document ID
- 5136227024438587922
- Author
- Kociolek L
- Gerding D
- Publication year
- Publication venue
- Journal of clinical microbiology
External Links
Snippet
Clostridium difficile strain BI/NAP1/027 is associated with increased C. difficile infection (CDI) rates and severity, and the efficacy of some CDI therapies may be strain dependent. Although cultured C. difficile isolates can be reliably subtyped by various methods, the long …
- 108010018157 nucleic acid probe 1 0 title abstract description 102
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/5695—Mycobacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
- C12Q1/6888—Hybridisation probes for detection or identification of organisms
- C12Q1/689—Hybridisation probes for detection or identification of organisms for bacteria
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F17/00—Digital computing or data processing equipment or methods, specially adapted for specific functions
- G06F17/30—Information retrieval; Database structures therefor; File system structures therefor
- G06F17/30286—Information retrieval; Database structures therefor; File system structures therefor in structured data stores
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving viable micro-organisms
- C12Q1/18—Testing for antimicrobial activity of a material
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F21/00—Security arrangements for protecting computers, components thereof, programs or data against unauthorised activity
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kociolek et al. | Clinical utility of laboratory detection of Clostridium difficile strain BI/NAP1/027 | |
| Tenover et al. | Comparison of strain typing results for Clostridium difficile isolates from North America | |
| Martin et al. | Characterization of Clostridium difficile strains isolated from patients in Ontario, Canada, from 2004 to 2006 | |
| Flight et al. | Rapid detection of emerging pathogens and loss of microbial diversity associated with severe lung disease in cystic fibrosis | |
| Humphries et al. | Performance of Clostridium difficile toxin enzyme immunoassay and nucleic acid amplification tests stratified by patient disease severity | |
| Hallin et al. | Validation of pulsed-field gel electrophoresis and spa typing for long-term, nationwide epidemiological surveillance studies of Staphylococcus aureus infections | |
| Tenover et al. | Antimicrobial-resistant strains of Clostridium difficile from North America | |
| Löfmark et al. | Inducible metronidazole resistance and nim genes in clinical Bacteroides fragilis group isolates | |
| Hu et al. | Sterilizing activities of fluoroquinolones against rifampin-tolerant populations of Mycobacterium tuberculosis | |
| Chavez-Bueno et al. | Inducible clindamycin resistance and molecular epidemiologic trends of pediatric community-acquired methicillin-resistant Staphylococcus aureus in Dallas, Texas | |
| Babady et al. | Evaluation of the Cepheid Xpert Clostridium difficile Epi assay for diagnosis of Clostridium difficile infection and typing of the NAP1 strain at a cancer hospital | |
| Huber et al. | Challenges for standardization of Clostridium difficile typing methods | |
| Quesada-Gómez et al. | Emergence of Clostridium difficile NAP1 in Latin America | |
| Eyre et al. | Comparison of multilocus variable-number tandem-repeat analysis and whole-genome sequencing for investigation of Clostridium difficile transmission | |
| Wieczorkiewicz et al. | Fluoroquinolone and macrolide exposure predict Clostridium difficile infection with the highly fluoroquinolone-and macrolide-resistant epidemic C. difficile strain BI/NAP1/027 | |
| Eyre et al. | Clostridium difficile mixed infection and reinfection | |
| Hu et al. | Prevalence and genetic characterization of second-line drug-resistant and extensively drug-resistant Mycobacterium tuberculosis in Rural China | |
| Fawley et al. | Use of highly discriminatory fingerprinting to analyze clusters of Clostridium difficile infection cases due to epidemic ribotype 027 strains | |
| Baldan et al. | Clostridium difficile PCR ribotype 018, a successful epidemic genotype | |
| Votintseva et al. | Multiple-strain colonization in nasal carriers of Staphylococcus aureus | |
| Liao et al. | A retrospective study of community-acquired Clostridium difficile infection in southwest China | |
| Carman et al. | In vivo selection of rifamycin-resistant Clostridium difficile during rifaximin therapy | |
| Islam et al. | Phenotypic, genotypic, and antibiotic sensitivity patterns of strains isolated from the cholera epidemic in Zimbabwe | |
| Ramsay et al. | Factors influencing acquisition of Burkholderia cepacia complex organisms in patients with cystic fibrosis | |
| Hung et al. | Predominance of Clostridium difficile ribotypes 017 and 078 among toxigenic clinical isolates in southern Taiwan |